$0.80
▼ $0.01 (-1.6%)
ONCY
Oncolytics Biotech Inc. Common Stock
Health Care
Investor Score
38F
Weak rating
Based on 6 of 7 weighted categories, computed from real, live financial data only.
18
Technical
54
Fundamental
40
Growth
38
Fair Value
50
News
—
Quality
42
Risk
Want the full breakdown — DCF fair value, technical indicators, news sentiment, and an AI-written narrative explaining this score?
View the full analysis (Hebrew) ←All raw data comes from real commercial financial data providers. This page is for educational purposes only and is not investment advice.